Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma

Rana R. McKay, MDAssociate Professor of Medicine and UrologyAssociate Director, Translational SciencesCo-Lead, Genitourinary Oncology Program Moores Cancer Center University of California San Diego3855 Health Sciences Drive La Jolla, CA 92037USAEric A. Singer, MD, MA, MS, FACS, FASCOThe Dave Longaberger Endowed Chair in UrologyProfessor of Urology and BioethicsChief, Division of Urologic OncologyDirector, Urologic Oncology FellowshipThe Ohio State University Comprehensive Cancer Center915 Olentangy River Road, Suite 3100, Columbus, OH, 43212USA

• Part 1. Localized Disease .- 1. Prognostic factors for localized Renal Cell Carcinoma.- 2. Active Surveillance of Patients with Clinically Localized Small Renal Masses.- 3. Partial Nephrectomy in the Treatment of RCC.- 4. Ablative Options for Renal Cell Carcinoma.- 5. Radical Nephrectomy for Renal Cell Carcinoma.- 6. Surgical Management of Hereditary Kidney Cancer Syndromes.- Part 2. Locally Advanced Disease .- 7. Management of Renal Cell Carcinoma with IVC Thrombus, Nodal Involvement, and T4 Disease.- 8. Adjuvant Therapies in Renal Cell Carcinoma.- 9. Neoadjuvant Therapy in Locally Advanced Renal Cell .- Part 3. Advanced Disease .- 10. Prognostic Factors in Advanced Renal Cell Carcinoma.- 11. Predictive biomarkers in advanced Renal Cell Carcinoma.- 12. First Line Systemic Treatment Options for Advanced Renal Cell Carcinoma.- 13. Subsequent Line Systemic Treatment Options for Advanced Renal Cell Carcinoma.- 14. Novel Targets in Development for Advanced Renal Cell Carcinoma.- 15. Role of Primary and Metastasis-Directed Stereotactic Radiation Therapy for Advanced Renal Cell Carcinoma..- 16. Systemic Therapies for Advanced Non-Clear Cell Renal Cell Carcinoma.- 17. Approaches to Special Populations with Advanced Renal Cell Carcinoma .- 18. Integration of Palliative Care into the Renal Cancer Treatment Paradigm.